📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition. (2020)

First Author: Dzama MM

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2020005037

PubMed Identifier: 32589720

Publication URI: http://europepmc.org/abstract/MED/32589720

Type: Journal Article/Review

Volume: 136

Parent Publication: Blood

Issue: 21

ISSN: 0006-4971